Oric Pharmaceuticals (ORIC) Current Assets (2019 - 2026)

Oric Pharmaceuticals' Current Assets history runs 8 years deep, the most recent figure standing at $290.2 million for Q1 2026.

• Quarterly Current Assets rose 37.27% year-over-year to $290.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $290.2 million (up 37.27% YoY) and the FY2025 annual result came in at $288.5 million, up 10.0% from the prior year.
• Current Assets was $290.2 million for Q1 2026 at Oric Pharmaceuticals, up from $288.5 million in the prior quarter.
• Across five years, Current Assets topped out at $324.1 million in Q1 2024 and bottomed at $193.2 million in Q1 2023.
• A 5-year average of $254.4 million and a median of $262.2 million in 2024 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2024 — Current Assets surged 67.78% — and 2025, when it tumbled 34.76%.
• Oric Pharmaceuticals' Current Assets stood at $210.5 million in 2022, then grew by 1.02% to $212.6 million in 2023, then increased by 23.36% to $262.2 million in 2024, then climbed by 10.0% to $288.5 million in 2025, then increased by 0.61% to $290.2 million in 2026.
• Business Quant data shows ORIC's Current Assets at $290.2 million in Q1 2026, $288.5 million in Q4 2025, and $295.6 million in Q3 2025.